Diagnosis and Management of Atrial Fibrillation

These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.

Event Name Diagnosis and Management of Atrial Fibrillation
Location Virtual - Joining link will be sent 24 hours prior
Start Date 12:00pm 16/11/2021
Finish Date 1:50pm 16/11/2021
Booking Closes 10:00am 16/11/2021
Places Available
Event Description

Join us on Tuesday 16th November for an educational webinar around the subject of 'Diagnosis and Management of Atrial Fibrillation'.

The webinar will commence at 12 noon and conclude at 1.50pm and include the following sessions:

 

An overview of the 2021 NICE AF Guidelines - Nazish Khan, Principal Pharmacist Cardiac Services,The Royal Wolverhampton Hospitals NHS Trust

Pharmacist led Atrial Fibrillation case finding programme and outcomes - Zainab Khanbhai, Senior Pharmacist, Cardiothoracic Surgery, Royal Brompton and Harefield Specialist Care

Patient self-monitoring of AF - Sotiris Antoniou, Consultant Pharmacist, Cardiovascular Medicine, Barts Health NHS Trust, Head of Pharmacy, St Bartholomew's Hospital, Lead Pharmacist for UCLP, Cardiovascular

Pharmacist-led Intervention to Prevent AF Related Strokes: A Model of Care - Jagjot Chahal, Highly Specialist Haematology Pharmacist, Barts Heart Centre, Pharmacy Department, St Bartholomew's Hospital

Facilitated Panel Discussion Group Panel discussion to include all speakers

  • Trends and Developments in AF Medicines Optimisation

 

Our webinars are sponsored by the pharmaceutical industry. However, the agenda for each webinar is independently managed, and developed by the internal Pharmacy Management team.

Agenda Download Agenda PDF
Contact Name Laura Carr
More Details Email for more details.
Your booking is always provisional until we confirm it!
Login Create Account
Website by MAXX Design

© 2021 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue